tiprankstipranks
Trending News
More News >
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market

Gyre Therapeutics (GYRE) Technical Analysis

Compare
811 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
3Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Gyre Therapeutics’s (GYRE) Moving Averages Convergence Divergence (MACD) indicator is -0.35, suggesting Gyre Therapeutics is a Buy.
Gyre Therapeutics’s (GYRE) 20-Day exponential moving average is 9.21, while Gyre Therapeutics’s (GYRE) share price is $8.41, making it a Sell.
Gyre Therapeutics’s (GYRE) 50-Day exponential moving average is 9.47, while Gyre Therapeutics’s (GYRE) share price is $8.41, making it a Sell.

Gyre Therapeutics (GYRE) Pivot Points

Jun 09, 2025, 07:39 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.82
7.37
7.67
8.22
8.52
9.07
9.37
Fibonacci
7.37
7.69
7.90
8.22
8.55
8.75
9.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Gyre Therapeutics (GYRE) Moving Averages

Jun 09, 2025, 07:39 PM
Period
Simple
Exponential
MA5
8.17Buy
8.42Sell
MA10
8.77Sell
8.82Sell
MA20
9.82Sell
9.21Sell
MA50
8.95Sell
9.47Sell
MA100
10.07Sell
9.98Sell
MA200
11.39Sell
10.96Sell
Gyre Therapeutics’s (GYRE) 10-Day exponential moving average is 8.82, while Gyre Therapeutics’s (GYRE) share price is $8.41, making it a Sell.
Gyre Therapeutics’s (GYRE) 100-Day exponential moving average is 9.98, while Gyre Therapeutics’s (GYRE) share price is $8.41, making it a Sell.
Gyre Therapeutics’s (GYRE) stock price is $8.41 and Gyre Therapeutics’s (GYRE) 50-day simple moving average is 8.95, creating a Sell signal.
Gyre Therapeutics’s (GYRE) stock price is $8.41 and Gyre Therapeutics’s (GYRE) 100-day simple moving average is 10.07, creating a Sell signal.
Gyre Therapeutics’s (GYRE) stock price is $8.41 and Gyre Therapeutics’s (GYRE) 200-day simple moving average is 11.39, creating a Sell signal.

Gyre Therapeutics (GYRE) Technical Indicators

Jun 09, 2025, 07:39 PM
Name
Value
Implied Action
RSI (14)
44.78
Neutral
STOCH (9,6)
18.36
Buy
STOCHRSI (14)
18.19
Buy
MACD (12,26)
-0.35
Buy
ADX (14)
25.38
Neutral
Williams %R
-79.40
Buy
CCI (14)
-102.55
Buy
ATR (14)
1.02
-
Ultimate Oscillator
33.52
Neutral
ROC
-25.90
Sell
Gyre Therapeutics’s (GYRE) Relative Strength Index (RSI) is 44.78, creating a Neutral signal.
Gyre Therapeutics’s (GYRE) Trend Strength Indicator (ADX) is 25.38, creating a Neutral signal.
Gyre Therapeutics’s (GYRE) Commodity Channel Index (CCI) is -102.55, creating a Buy signal.
Gyre Therapeutics’s (GYRE) Price Rate of Change (ROC) is -25.90, creating a Sell signal.

FAQ

Is GYRE a Buy, Hold, or Sell?
Based on GYRE’s technical indicators, GYRE is a Sell.
    What is GYRE’s RSI (14)?
    GYRE’s RSI (14) is 44.78, which suggests GYRE is a Neutral.
      What is GYRE’s MACD?
      GYRE’s MACD is -0.35, which suggests GYRE is a Buy.
        What is GYRE’s 5-day moving average?
        GYRE’s 5-day moving average is 8.17, which suggests GYRE is a Buy.
          What is GYRE’s 20-day moving average?
          GYRE 20-day moving average is 9.82, which suggests GYRE is a Sell.
            What is GYRE’s 50-day moving average?
            GYRE’s 50-day moving average is 8.95, which suggests GYRE is a Sell.
              What is GYRE’s 200-day moving average?
              GYRE’s 200-day moving average is 11.39, which suggests GYRE is a Sell.
                What is GYRE’s Williams % R (14)?
                GYRE’s Williams % R (14) is -79.40, which suggests GYRE is a Buy.
                  What is GYRE’s CCI (14)?
                  GYRE’s CCI (14) is -102.55, which suggests GYRE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis